Private equity firms account for 47% of Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) ownership, while institutions account for 33% [Yahoo! Finance]
Lexicon Pharmaceuticals, Inc. (LXRX)
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
lexpharma.com/investors
Company Research
Source: Yahoo! Finance
61% of the business is held by the top 2 shareholders Institutions own 33% of Lexicon Pharmaceuticals To get a sense of who is truly in control of Lexicon Pharmaceuticals, Inc. ( NASDAQ:LXRX ), it is important to understand the ownership structure of the business. We can see that private equity firms own the lion's share in the company with 47% ownership. Put another way, the group faces the maximum upside potential (or downside risk). Institutions, on the other hand, account for 33% of the company's stockholders. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. In the chart below, we zoom in on the different ownership groups of Lexicon Pharmaceuticals. View our latest analysis for Lexicon Pharmaceuticals NasdaqGS:LXRX Ownership Breakdown December 30th 2024 What Does The Institutional Ownership Tell Us About Lexicon Pharmaceuticals? Many institutions measure their performance against an index th
Show less
Read more
Impact Snapshot
Event Time:
LXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LXRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LXRX alerts
High impacting Lexicon Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
LXRX
News
- Lexicon Appoints Scott Coiante as Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Lexicon Appoints Scott Coiante as Chief Financial OfficerGlobeNewswire
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin) [Yahoo! Finance]Yahoo! Finance
- Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)GlobeNewswire
LXRX
Earnings
- 11/12/24 - Miss
LXRX
Sec Filings
- 1/2/25 - Form 4
- 1/2/25 - Form 3
- 1/2/25 - Form 8-K
- LXRX's page on the SEC website